Who owns CHEMOMAB THERAPEUTICS LTD SPONSORED ADS?
- Ticker: CMMB
- CUSIP Number: 16385c203
Tip: Access positions for across all investors
Analyze quarterly positions in Chemomab Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Chemomab Therapeutics stock
Who bought or sold CHEMOMAB THERAPEUTICS LTD SPONSORED ADS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| ADAR1 Capital Management | 80k | $132k | 100% | Dec 2025 |
|
| Ikarian Capital | 52k | $86k | -3% | Dec 2025 |
|
| Kestra Private Wealth Services | 52k | $85k | 100% | Dec 2025 |
|
| XTX Topco | 19k | $31k | 100% | Dec 2025 |
|
| Rhumbline Advisers | 18k | $30k | 88% | Dec 2025 |
|
| Jane Street | 16k | $26k | -27% | Dec 2025 |
|
| Virtu Financial | 11k | $18k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 8.1k | $13k | 41% | Dec 2025 |
|
| GAMMA Investing | 2.5k | $4.1k | 277% | Dec 2025 |
|
| UBS Group | 2.3k | $3.7k | 2176% | Dec 2025 |
|
| SBI Securities | 26.00 | $42.998800 | 0% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 2.00 | $3.000000 | 100% | Dec 2025 |
|
Who sold out of Chemomab Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sphera Funds Management | Sep 2025 | 179k | $472k |
| Stonepine Capital Management | Sep 2025 | 30k | $79k |